Class Certification Sought In Shareholder Suit Over COVID-19 Vaccine Statements

Mealey's (August 3, 2021, 9:08 AM EDT) -- PHILADELPHIA — Shareholders in a securities class action against a biotechnology company and three of its senior executives, who allegedly misrepresented the company’s development and manufacturing capabilities for its COVID-19 vaccine...
To view the full article, register now.